Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ECE1 | P42892 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.43 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CD74 | P04233 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28804696 | 0.80 | HDAC1 (0.42) | HDAC1HDAC6ECE1 | |
| SCHEMBL2056290 | 0.77 | HDAC1 (0.51) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL11052563 | 0.77 | HDAC1 (0.51) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL6848047 | 0.77 | ALDH1A1 (0.61) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL6123166 | 0.77 | HDAC1 (0.55) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL8432354 | 0.77 | HDAC1 (0.51) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL14133319 | 0.76 | ALDH1A1 (0.64) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL5656467 | 0.74 | HDAC1 (0.55) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL10918996 | 0.74 | HDAC1 (0.58) | HDAC1HDAC6HDAC8ALDH1A1RAB9A | |
| SCHEMBL10916542 | 0.74 | HDAC1 (0.53) | HDAC1HDAC6HDAC8ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11548012-B2 | Process to treat metal or mineral ores and collector composition therefor | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2023-01-10 | — | — | US | claimed |
| US-20210197210-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2021-07-01 | — | — | US | claimed |
| EP-3600678-B1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INT BV (NL) | 2021-05-05 | — | — | EP | claimed |
| EP-3697540-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | Nouryon Chemicals International B.V. (NL) | 2020-08-26 | — | — | EP | claimed |
| EP-3636346-A1 | PROCESS TO TREAT ORES AND COLLECTOR COMPOSITION THEREFOR | Nouryon Chemicals International B.V. (NL) | 2020-04-15 | — | — | EP | claimed |
| US-20200048735-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-02-13 | — | — | US | claimed |
| EP-3600678-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | Nouryon Chemicals International B.V. (NL) | 2020-02-05 | — | — | EP | claimed |
| US-20080308466-A1 | Mineral Recovery from Ore | LUMSDEN BARRY GRAHAM | 2008-12-18 | — | — | US | claimed |
| EP-1951433-A1 | IMPROVING MINERAL RECOVERY FROM ORE | Lumsden, Barry Graham (AU) | 2008-08-06 | — | — | EP | claimed |
| WO-2007059559-A1 | IMPROVING MINERAL RECOVERY FROM ORE | LUMSDEN BARRY GRAHAM (AU) | 2007-05-31 | — | — | WO | claimed |
| US-4414312-A | Photopolymerizable polyamide ester resin compositions containing an oxygen scavenger | E. I. DU PONT DE NEMOURS & CO. (US) | 1983-11-08 | — | — | US | claimed |
| US-11578210-B2 | Asphalt binders containing a glyceride and fatty acid mixture and methods for making and using same | FLINT HILL RESOURCES, LP (US) | 2023-02-14 | — | — | US | disclosed |
| US-11548012-B2 | Process to treat metal or mineral ores and collector composition therefor | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2023-01-10 | — | — | US | disclosed |
| EP-3697540-B1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION WITH A DIMERIC NITRILE | NOURYON CHEMICALS INT BV (NL) | 2022-09-28 | — | — | EP | disclosed |
| US-20210197210-A1 | PROCESS TO TREAT METAL OR MINERAL ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2021-07-01 | — | — | US | disclosed |
| US-6548676-B1 | Halogenation or sulfonylation of 5-methylol-2-sulfanyl-thiazole derivatives; separation, salt formation | SYNGENTA CROP PROTECTION, INC. | 2003-04-15 | — | — | US | disclosed |
| EP-1201662-A1 | Preparation of thiazoles | Syngenta Participations AG (CH) | 2002-05-02 | — | — | EP | disclosed |
| EP-0946532-A1 | PREPARATION OF THIAZOLES | Novartis AG (CH) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998027075-A1 | PREPARATION OF THIAZOLES | NOVARTIS AG (CH) | 1998-06-25 | — | — | WO | disclosed |
| US-3969289-A | One-part foamable latex composition | GENERAL LATEX AND CHEMICAL CORPORATION (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548012-B2 | Process to treat metal or mineral ores and collector composition therefor | AFF4, FFAR4, FUS | HDAC1 2007/4885HDAC6 1106/4885HDAC8 2257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.